David Mosedale Email & Phone Number

Cambridge, GB

Cambridge, GB

Cambridge, Cambs, GB

CTO of Methuselah Health UK Ltd., a start-up drug discovery company founded in 2014 by Index Ventures (now Medicxi Ventures) to study the role of proteome instability in a number of human diseases linked to ageing.We are developing analytical platforms for the detection of post-translational modifications across many different proteins. These platforms are.

CSO of Total Scientific, who provide a range of contract research services, including general laboratory work, metabolomics, clinical studies, biomarker research and assay development services.We specialise in providing scientific excellence, with most of our client requests being for custom work rather than off-the-shelf studies.

As VP R&D at Pronostics Ltd. I was responsible for bringing a range of multiplex diagnostic tests, primarily in the field of autoimmunity, from early stage development through to CE marking and ready for the clinic, under ISO 13485 guidelines.

Cambridge, Cambridgeshire, GB

As a principal investigator in the Translational Research Unit I was responsible for running academic clinical studies. Primarily, I ran the Metabonomics and Genomics in Heart Diseaes (MaGiCAD) study, a 1334-person study investigating the diagnosis of heart disease, and remain Chair of the MaGiCAD Management Committee.

Cambridge, England, GB

During my time at the University of Cambridge I worked as a post-doc in Dr. David Grainger's group in the Department of Medicine at Addenbrooke's Hospital. I primarily investigated the biology of transforming growth factor-beta and diagnosis of cardiovascular disease through the development of novel assays.